apparatus Radleys company for chemical reaction condition control.

• Legal notice:
  

  Copyright (c) Pielaszek Research, all rights reserved.
  The above materials, including auxiliary resources, are subject to Publisher's copyright and the Author(s) intellectual rights. Without limiting Author(s) rights under respective Copyright Transfer Agreement, no part of the above documents may be reproduced without the express written permission of Pielaszek Research, the Publisher. Express permission from the Author(s) is required to use the above materials for academic purposes, such as lectures or scientific presentations.
  In every case, proper references including Author(s) name(s) and URL of this webpage: https://science24.com/paper/14684 must be provided.

1. The comparison of the stability indicating  two HPLC methods and their application for the determination of bosentan in coated tablets 
2. Elaboration of travoprost eye drops formulation.
3. What modern crystallography can add to pharmaceutical research?
4. Antiproliferative and cytotoxic effect of vitamin D₃ and its derivatives on the selected cells with a higher proliferative potential
5. Improved manufacturing process of bosentan monohydrate.
6. Characterization of dutasteride polymorphic forms
7. Preparation and physicochemical properties of crystalline forms and amorphous pemetrexed disodium
8. Pharmaceutical  technologies  – why do they have to be innovative
9. A novel convergent synthesis of the prostaglandin F_2α analogues
10. Comparative permeation studies of tacalcitol through the human skin from brand product versus generic product
11. HPLC method for determination of the enantiomeric purity of a new ω chain aldehyde synthon used in the synthesis of travoprost
12. Physicochemical characterization of sunitinib and its impurities
13. Vitamin D analogs enhance the activity of imatinib mesylate in human non-small cell lung cancer model
14. Colon cancer treatment with the use of vitamin D analogs and irinotecan 
15. Distinguishing between polymorphic forms of linezolid by solid-phase electronic and vibrational circular dichroism
16. Preparation of protoaescigenin from escin.
17. Experimental and theoretical charge density studies on a model analogue of vitamin D
18. Synthetic Technologies of Pharmaceutical Substances
19. Structural characterization of PX-S
20. The influence of (24R)-1,24- dihydroxyvitamin D₃ on the anticancer activity of 5-fluorouracil in human colon cancer model
21. The use of the hyphenated LC-MS/MS technique for the characterisation of impurity profile of Quetiapine during drug development
22. A novel synthesis of 19-nor analogs of vitamin D
23. The influence of novel analogs of vitamin D₃ on the antiproliferative activity of cisplatin or doxorubicin on human promyelocytic leukaemia cell line HL-60 
24. Quantification of active substance in drug by Rietveld analysis
25. Isolation, structural elucidation and characterization of impurities in latanoprost
26. New rosiglitazone salts
27. New calcipotriol analogs, their toxicity and antitumor activity in vivo in comparison to the affinity with VDR and DBP
28. Optimization of AR-3 synthesis
29. Polimorphism of Active Pharmaceutical Ingredients
30. CHARACTERIZATION OF ARIPIPRAZOLE SOLVATE WITH ETHANOL AND POLYMORPHIC FORMS PRODUCED DURING ITS HEATING
31. THE VALIDATION OF ANALYTICAL METHODS OF A PHARMACEUTICAL ACTIVE SUBSTANCE PRODUCED IN SMALL SCALE PLANT (SSP). THE EXAMPLE OF PIOGLITAZONE HYDROCHLORIDE.
32. ANTITUMOR EFFECT OF CISPLATIN OR FLUOROURACIL IN COMBINED TREATMENT WITH (24R)-1,24-DIHYDROXYVITA- MIN D₃
33. COMBINATION OF: IMATINIB, PRI-2191 AND CYTOSTATICS - THE ANTIPROLIFERATIVE EFFECTS ON HL-60 LEUKEMIA CELL LINE
34. ANTIPROLIFERATIVE ACTIVITY IN VITRO OF DIASTEREOMERIC ANALOGUES OF VITAMIN D3 AGAINST NORMAL AND CANCER CELL LINES